Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan

Overview of attention for article published in Patient preference and adherence, July 2016

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 41 followers.

Three-year outcome of naftopidil for BPH/LUTS https://t.co/abeTlAcHum

Reply Repost Favourite

Three-year outcome of naftopidil for BPH/LUTS https://t.co/YFQcOk42G8

Reply Repost Favourite